100 related articles for article (PubMed ID: 30672325)
1. Investigation of TF-binding lectins from dietary sources and SRL on proliferation and cell cycle progression in human colon HT29 and SW620 cells.
Belur S; Barkeer S; Swamy BM; Yu LG; Inamdar SR
Nutr Cancer; 2019; 71(4):634-642. PubMed ID: 30672325
[TBL] [Abstract][Full Text] [Related]
2. Opposite effects on human colon cancer cell proliferation of two dietary Thomsen-Friedenreich antigen-binding lectins.
Yu LG; Milton JD; Fernig DG; Rhodes JM
J Cell Physiol; 2001 Feb; 186(2):282-7. PubMed ID: 11169464
[TBL] [Abstract][Full Text] [Related]
3. The TF-antigen binding lectin from Sclerotium rolfsii inhibits growth of human colon cancer cells by inducing apoptosis in vitro and suppresses tumor growth in vivo.
Inamdar SR; Savanur MA; Eligar SM; Chachadi VB; Nagre NN; Chen C; Barclays M; Ingle A; Mahajan P; Borges A; Shastry P; Kalraiya RD; Swamy BM; Rhodes JM; Yu LG
Glycobiology; 2012 Sep; 22(9):1227-35. PubMed ID: 22653662
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanism of anticancer effect of Sclerotium rolfsii lectin in HT29 cells involves differential expression of genes associated with multiple signaling pathways: A microarray analysis.
Barkeer S; Guha N; Hothpet V; Saligrama Adavigowda D; Hegde P; Padmanaban A; Yu LG; Swamy BM; Inamdar SR
Glycobiology; 2015 Dec; 25(12):1375-91. PubMed ID: 26347523
[TBL] [Abstract][Full Text] [Related]
5. Sclerotium rolfsii lectin induces opposite effects on normal PBMCs and leukemic Molt-4 cells by recognising TF antigen and its variants as receptors.
Chachadi VB; Pujari R; Shastry P; Swamy BM; Inamdar SR
Glycoconj J; 2020 Apr; 37(2):251-261. PubMed ID: 31900725
[TBL] [Abstract][Full Text] [Related]
6. Sclerotium rolfsii lectin inhibits proliferation and induces apoptosis in human ovarian cancer cell line PA-1.
Eligar SM; Pujari R; Swamy BM; Shastry P; Inamdar SR
Cell Prolif; 2012 Oct; 45(5):397-403. PubMed ID: 22805123
[TBL] [Abstract][Full Text] [Related]
7. Reversible inhibition of proliferation of epithelial cell lines by Agaricus bisporus (edible mushroom) lectin.
Yu L; Fernig DG; Smith JA; Milton JD; Rhodes JM
Cancer Res; 1993 Oct; 53(19):4627-32. PubMed ID: 8402638
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics, biodistribution and antitumour effects of Sclerotium rolfsii lectin in mice.
Anupama S; Laha P; Sharma M; Pathak K; Bane S; Ingle AD; Gota V; Kalraiya RD; Yu LG; Rhodes JM; Swamy BM; Inamdar SR
Oncol Rep; 2017 May; 37(5):2803-2810. PubMed ID: 28394001
[TBL] [Abstract][Full Text] [Related]
9. Sclerotium rolfsii lectin induces stronger inhibition of proliferation in human breast cancer cells than normal human mammary epithelial cells by induction of cell apoptosis.
Savanur MA; Eligar SM; Pujari R; Chen C; Mahajan P; Borges A; Shastry P; Ingle A; Kalraiya RD; Swamy BM; Rhodes JM; Yu LG; Inamdar SR
PLoS One; 2014; 9(11):e110107. PubMed ID: 25364905
[TBL] [Abstract][Full Text] [Related]
10. Peanut lectin: a mitogen for normal human colonic epithelium and human HT29 colorectal cancer cells.
Ryder SD; Smith JA; Rhodes JM
J Natl Cancer Inst; 1992 Sep; 84(18):1410-6. PubMed ID: 1512792
[TBL] [Abstract][Full Text] [Related]
11. Exquisite binding specificity of Sclerotium rolfsii lectin toward TF-related O-linked mucin-type glycans.
Chachadi VB; Inamdar SR; Yu LG; Rhodes JM; Swamy BM
Glycoconj J; 2011 Jan; 28(1):49-56. PubMed ID: 21347715
[TBL] [Abstract][Full Text] [Related]
12. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib.
Grösch S; Tegeder I; Niederberger E; Bräutigam L; Geisslinger G
FASEB J; 2001 Dec; 15(14):2742-4. PubMed ID: 11606477
[TBL] [Abstract][Full Text] [Related]
13. Efficacy studies of Sclerotium rolfsii lectin on breast cancer using NOD SCID mouse model.
Hegde P; Narasimhappagari J; Swamy BM; Inamdar SR
Chem Biol Drug Des; 2018 Aug; 92(2):1488-1496. PubMed ID: 29675931
[TBL] [Abstract][Full Text] [Related]
14. Molecular Cloning, Carbohydrate Specificity and the Crystal Structure of Two Sclerotium rolfsii Lectin Variants.
Peppa VI; Venkat H; Kantsadi AL; Inamdar SR; Bhat GG; Eligar S; Shivanand A; Chachadi VB; Satisha GJ; Swamy BM; Skamnaki VT; Zographos SE; Leonidas DD
Molecules; 2015 Jun; 20(6):10848-65. PubMed ID: 26076107
[TBL] [Abstract][Full Text] [Related]
15. Anti-tumor role of Bacillus subtilis fmbJ-derived fengycin on human colon cancer HT29 cell line.
Cheng W; Feng YQ; Ren J; Jing D; Wang C
Neoplasma; 2016; 63(2):215-22. PubMed ID: 26774143
[TBL] [Abstract][Full Text] [Related]
16. Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes.
Solvason N; Wu WW; Kabra N; Wu X; Lees E; Howard MC
J Exp Med; 1996 Aug; 184(2):407-17. PubMed ID: 8760794
[TBL] [Abstract][Full Text] [Related]
17. Cyclic AMP negatively controls c-myc transcription and G1 cell cycle progression in p210 BCR-ABL transformed cells: inhibitory activity exerted through cyclin D1 and cdk4.
Williamson EA; Burgess GS; Eder P; Litz-Jackson S; Boswell HS
Leukemia; 1997 Jan; 11(1):73-85. PubMed ID: 9001421
[TBL] [Abstract][Full Text] [Related]
18. Cell surface-expressed Thomsen-Friedenreich antigen in colon cancer is predominantly carried on high molecular weight splice variants of CD44.
Singh R; Campbell BJ; Yu LG; Fernig DG; Milton JD; Goodlad RA; FitzGerald AJ; Rhodes JM
Glycobiology; 2001 Jul; 11(7):587-92. PubMed ID: 11447138
[TBL] [Abstract][Full Text] [Related]
19. Use of a biosensor to determine the binding kinetics of five lectins for Galactosyl-N-acetylgalactosamine.
Milton JD; Fernig DG; Rhodes JM
Glycoconj J; 2001 Jul; 18(7):565-9. PubMed ID: 12151718
[TBL] [Abstract][Full Text] [Related]
20. Peanut lectin stimulates proliferation of colon cancer cells by interaction with glycosylated CD44v6 isoforms and consequential activation of c-Met and MAPK: functional implications for disease-associated glycosylation changes.
Singh R; Subramanian S; Rhodes JM; Campbell BJ
Glycobiology; 2006 Jul; 16(7):594-601. PubMed ID: 16571666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
